A double‐blind, placebo‐controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea‐predominant IBS

Background Micro‐inflammation is considered an element in the pathogenesis of irritable bowel syndrome (IBS). High‐sensitivity C reactive protein (hs‐CRP) was previously shown to be higher in IBS compared to healthy controls, albeit within the normal range. Since probiotics may suppress micro‐inflam...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurogastroenterology and motility 2017-07, Vol.29 (7), p.n/a
Hauptverfasser:	Hod, K., Sperber, A. D., Ron, Y., Boaz, M., Dickman, R., Berliner, S., Halpern, Z., Maharshak, N., Dekel, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biomarkers - metabolism C-reactive protein calprotectin Clinical trials Diarrhea Diarrhea - diet therapy Diarrhea - metabolism Diarrhea - physiopathology Double-Blind Method Double-blind studies Fc receptors FDA approval Feces Female Follow-Up Studies Gastrointestinal tract hs‐CRP Humans Inflammation Inflammation Mediators - antagonists & inhibitors Inflammation Mediators - metabolism Intestine Irritable bowel syndrome Irritable Bowel Syndrome - diet therapy Irritable Bowel Syndrome - metabolism Irritable Bowel Syndrome - physiopathology Middle Aged Placebo Effect Probiotics Probiotics - administration & dosage Prospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!